Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies

NCT00288444 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00288444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00288444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2006
Completion date
March 31, 2009
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal carcinoma, lung cancer, prostate cancer, soft tissue sarcoma